Polyetheretherketone/nano-fluorohydroxyapatite composite with antimicrobial activity and osseointegration properties

Biomaterials

Volumn 35, Issue 25, 2014, Pages 6758-6775

  Wang, Lixin ^a   He, Shu ^b,d   Wu, Xiaomian ^c,d   Liang, Shanshan ^e   Mu, Zhonglin ^e   Wei, Jie ^f   Deng, Feng ^c   Deng, Yi ^d   Wei, Shicheng ^b,c,d  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

^d PEKING UNIVERSITY   (China)

^e HAINAN MEDICAL UNIVERSITY   (China)

^f East China University of Science and Technology   (China)

Author keywords

Antimicrobial; Bioactivity; Fluorohydroxyapatite; Implant; Osseointegration; Polyetheretherketone

Indexed keywords

BIOACTIVITY; BIOCOMPATIBILITY; BLENDING; BONE; CELL ADHESION; COMPUTERIZED TOMOGRAPHY; DENTAL PROSTHESES; IMPLANTS (SURGICAL); PHOSPHATASES; POLYETHER ETHER KETONES; TISSUE ENGINEERING;

ALKALINE PHOSPHATASE ACTIVITY; ANTIMICROBIAL; DENTAL IMPLANT APPLICATIONS; DENTAL TISSUE ENGINEERING; FLUOROHYDROXYAPATITE; HISTOMORPHOMETRIC ANALYSIS; OSSEOINTEGRATION; OSSEOINTEGRATION PROPERTIES;

COMPOSITE MATERIALS;

ALKALINE PHOSPHATASE; CALCEIN; HYDROXYAPATITE; NANO FLUOROHYDROXYAPATITE; NANOMATERIAL; POLYETHERETHERKETONE; TETRACYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BIOMATERIAL; FLUOROHYDROXYAPATITE; KETONE; MACROGOL DERIVATIVE;

ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; APOPTOSIS; ARTICLE; ATOMIC FORCE MICROSCOPY; BIOCOMPATIBILITY; BLOOD COMPATIBILITY; BONE DEVELOPMENT; BONE MASS; BONE REGENERATION; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EXPERIMENTAL DOG; HARDNESS; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; MALE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE ADHESION; TOOTH; TOOTH IMPLANT; X RAY PHOTOELECTRON SPECTROSCOPY; YOUNG MODULUS; BACTERIUM ADHERENCE; BIOFILM; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; MATERIALS TESTING; METABOLISM; STREPTOCOCCUS MUTANS; TUMOR CELL LINE;

BACTERIA (MICROORGANISMS);

ALKALINE PHOSPHATASE; ANTI-INFECTIVE AGENTS; BACTERIAL ADHESION; BIOCOMPATIBLE MATERIALS; BIOFILMS; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; HYDROXYAPATITES; KETONES; MATERIALS TESTING; NANOSTRUCTURES; OSSEOINTEGRATION; POLYETHYLENE GLYCOLS; STREPTOCOCCUS MUTANS; X-RAY MICROTOMOGRAPHY;

EID: 84902121116     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.04.085     Document Type: Article

References (66)

1. Feng Y.-F., Wang L., Zhang Y., Li X., Ma Z.-S., Zou J.-W., et al. Effect of reactive oxygen species overproduction on osteogenesis of porous titanium implant in the present of diabetes mellitus. Biomaterials 2013, 34:2234-2243.
2. Andersen O.Z., Offermanns V., Sillassen M., Almtoft K.P., Andersen I.H., Sørensen S., et al. Accelerated bone ingrowth by local delivery of strontium from surface functionalized titanium implants. Biomaterials 2013, 34:5883-5890.
3. Sagomonyants K.B., Jarman-Smith M.L., Devine J.N., Aronow M.S., Gronowicz G.A. The invitro response of human osteoblasts to polyetheretherketone (PEEK) substrates compared to commercially pure titanium. Biomaterials 2008, 29:1563-1572.
4. Huiskes R., Weinans H., Van Rietbergen B. The relationship between stress shielding and bone resorption around total hip stems and the effects of flexible materials. Clin Orthop Relat Res 1992, 274:124-134.
5. Niki Y., Matsumoto H., Otani T., Suda Y., Toyama Metal ion concentrations in the joint fluid immediately after total knee arthroplasty. Mod Rheumatol 2001, 11:192-196.
6. Kurtz S.M., Devine J.N. PEEK biomaterials in trauma, orthopedic, and spinal implants. Biomaterials 2007, 28:4845-4869.
7. Toth J.M., Wang M., Estes B.T., Scifert J.L., Seim H.B., Turner A.S. Polyetheretherketone as a biomaterial for spinal applications. Biomaterials 2006, 27:324-334.
8. Wang H.Y., Xu M., Zhang W., Kwok D.T.K., Jiang J.A., Wu Z.W., et al. Mechanical and biological characteristics of diamond-like carbon coated poly aryl-ether-ether-ketone. Biomaterials 2010, 31:8181-8187.
9. Lustiger A., Uralil F.S., Newaz G.M. Processing and structural optimization of PEEK composites. Polym Compos 1990, 11:65-75.
10. Bakar A., Cheng M., Tang S., Yu S., Liao K., Tan C., et al. Tensile properties, tension-tension fatigue and biological response of polyetheretherketone-hydroxyapatite composites for load-bearing orthopedic implants. Biomaterials 2003, 24:2245-2250.
11. Ponnappan R.K., Serhan H., Zarda B., Patel R., Albert T., Vaccaro A.R. Biomechanical evaluation and comparison of polyetheretherketone rod system to traditional titanium rod fixation. Spine J 2009, 9:263-267.
12. Nieminen T., Kallela I., Wuolijoki E., Kainulainen H., Hiidenheimo I., Rantala I. Amorphous and crystalline polyetheretherketone: mechanical properties and tissue reactions during a 3-year follow-up. JBiomed Mater Res A 2008, 84:377-383.
13. Cutler A.R., Siddiqui S., Avinash L.M., Hillard V.H., Cerabona F., Das K. Comparison of polyetheretherketone cages with femoral cortical bone allograft as a single-piece interbody spacer in transforaminal lumbar interbody fusion. JNeurosurg-Spine 2006, 5:534-539.
14. Song K.-J., Taghavi C.E., Hsu M.S., Lee K.-B., Kim G.-H., Song J.-H. Plate augmentation in anterior cervical discectomy and fusion with cage for degenerative cervical spinal disorders. Eur Spine J 2010, 19:1677-1683.
15. Vadapalli S., Sairyo K., Goel V.K., Robon M., Biyani A., Khandha A., et al. Biomechanical rationale for using polyetheretherketone (PEEK) spacers for lumbar interbody fusion-a finite element study. Spine 2006, 31:E992-E998.
16. Rivard C.H., Rhalmi S., Coillard C. Invivo biocompatibility testing of peek polymer for a spinal implant system: a study in rabbits. JBiomed Mater Res 2002, 62:488-498.
17. Sun Y., Deng Y., Ye Z., Liang S., Tang Z., Wei S. Peptide decorated nano-hydroxyapatite with enhanced bioactivity and osteogenic differentiation via polydopamine coating. Colloids Surf B: Biointerfaces 2013, 111:107-116.
18. Wong K., Wong C., Liu W., Pan H., Fong M., Lam W., et al. Mechanical properties and invitro response of strontium-containing hydroxyapatite/polyetheretherketone composites. Biomaterials 2009, 30:3810-3817.
19. Ma R., Weng L., Bao X., Song S., Zhang Y. Invivo biocompatibility and bioactivity of in situ synthesized hydroxyapatite/polyetheretherketone composite materials. JAppl Polym Sci 2013, 127:2581-2587.
20. Poeder R.K., Conrad T.L. Bioactive polyaryletheretherketone composites. PEEK biomaterials handbook 2011, 163-169. Elsevier. S.M. Kurtz (Ed.).
21. Mouhyi J., Dohan Ehrenfest D.M., Albrektsson T. The peri-implantitis: implant surfaces, microstructure, and physicochemical aspects. Clin Implant Dent R 2012, 14:170-183.
22. Broggini N., McManus L., Hermann J., Medina R., Schenk R., Buser D., et al. Peri-implant inflammation defined by the implant-abutment interface. JDent Res 2006, 85:473-478.
23. Campoccia D., Montanaro L., Arciola C.R. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials 2006, 27:2331-2339.
24. Sanpo N., Tan M.L., Cheang P., Khor K.A. Antibacterial property of cold-sprayed HA-Ag/PEEK coating. JTherm Spray Techn 2009, 18:10-15.
25. Kakinuma H., Ishii K., Ishihama H., Honda M., Toyama Y., Mstsumoto M., et al. Antibacterial polyetheretherketone implants immobilized with silver ions based on chelate-bonding ability of inositol phosphate: processing, material characterization, cytotoxicity, and antibacterial properties. JBiomed Mater Res A 2014, 10.1002/jbm.a.35157.
26. Sandukas S., Yamamoto A., Rabiei A. Osteoblast adhesion to functionally graded hydroxyapatite coatings doped with silver. JBiomed Mater Res A 2011, 97:490-497.
27. Albers C.E., Hofstetter W., Siebenrock K.A., Landmann R., Klenke F.M. Invitro cytotoxicity of silver nanoparticles on osteoblasts and osteoclasts at antibacterial concentrations. Nanotoxicology 2013, 7:30-36.
28. Kim Y.S., Song M.Y., Park J.D., Song K.S., Ryu H.R., Chung Y.H., et al. Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol 2010, 7:20-30.
29. Tahriri M., Moztarzadeh F. Preparation, characterization, and invitro biological evaluation of PLGA/nano-fluorohydroxyapatite (FHA) microsphere-sintered scaffolds for biomedical applications. Appl Biochem Biotechnol 2014, 172:2465-2479.
30. Gineste L., Gineste M., Ranz X., Ellefterion A., Guilhem A., Ronquet N., et al. Degradation of hydroxylapatite, fluorapatite and fluorhydroxyapatite coatings of dental implants in dogs. JBiomed Mater Res 1999, 48:224-234.
31. Campccia D., Arciola C.R., Cervellati M., Maltarello M.C., Montanaro Invitro behaviour of bone marrow-derived mesenchymal cells cultured on fluorohydroxyapatite-coated substrata with different roughness. Biomaterials 2003, 24:587-596.
32. Wiegand A., Buchalla W., Attin T. Review on fluoride-releasing restorative materials-fluoride release and uptake characteristics, antibacterial activity and influence on caries formation. Dent Mater 2007, 23:343-362.
33. Stanić V., Dimitrijević S., Antonović D.G., Jokić B.M., Zec S.P., Tanasković S.T., et al. Synthesis of fluorine substituted hydroxyapatite nanopowders and application of the central composite design for determination of its antimicrobial effects. Appl Surf Sci 2014, 290:346-352.
34. Bobyn J.D., Stackpool G.J., Hacking S.A., Tanzer M., Krygier J.J. Characteristics of bone ingrowth and interface mechanics of a new porous tantalum biomaterial. JBone Joint Surg Br 1999, 81-B:907-914.
35. 2/PEEK bioactive composite as a bone substitute material: invitro and invivo studies. Int J Nanomedicine 2012, 7:1215.
36. Kannan S., Rocha J., Agathopoulos S., Ferreira J. Fluorine-substituted hydroxyapatite scaffolds hydrothermally grown from aragonitic cuttlefish bones. Acta Biomater 2007, 3:243-249.
37. Deng Y., Sun Y., Chen X., Zhu P., Wei S. Biomimetic synthesis and biocompatibility evaluation of carbonated apatites template-mediated by heparin. Mat Sci Eng C-Mater 2013, 33:2905-2913.
38. Li Q., Li M., Zhu P., Wei S. Invitro synthesis of bioactive hydroxyapatite using sodium hyaluronate as a template. JMater Chem 2012, 22:20257-20265.
39. Zhao Y., Wong H.M., Wang W., Li P., Xu Z., Chong E.Y., et al. Cytocompatibility, osseointegration, and bioactivity of three-dimensional porous and nanostructured network on polyetheretherketone. Biomaterials 2013, 34:9264-9277.
40. Yu S., Hariram K.P., Kumar R., Cheang P., Aik K.K. Invitro apatite formation and its growth kinetics on hydroxyapatite/polyetheretherketone biocomposites. Biomaterials 2005, 26:2343-2352.
41. Brett P., Harle J., Salih V., Mihoc R., Olsen I., Jones F., et al. Roughness response genes in osteoblasts. Bone 2004, 35:124-133.
42. Kim M.-J., Choi M.-U., Kim C.-W. Activation of phospholipase D1 by surface roughness of titanium in MG63 osteoblast-like cell. Biomaterials 2006, 27:5502-5511.
43. Rosales-Leal J., Rodríguez-Valverde M., Mazzaglia G., Ramon-Torregrosa P., Diaz-Rodriguez L., Garcia-Martinez O., et al. Effect of roughness, wettability and morphology of engineered titanium surfaces on osteoblast-like cell adhesion. Colloid Surface A 2010, 365:222-229.
44. Converse G.L., Yue W., Roeder R.K. Processing and tensile properties of hydroxyapatite-whisker-reinforced polyetheretherketone. Biomaterials 2007, 28:927-935.
45. Kim H.-W., Lee E.-J., Kim H.-E., Salih V., Knowles J.C. Effect of fluoridation of hydroxyapatite in hydroxyapatite-polycaprolactone composites on osteoblast activity. Biomaterials 2005, 26:4395-4404.
46. Qu H., Wei M. The effect of fluoride contents in fluoridated hydroxyapatite on osteoblast behavior. Acta Biomater 2006, 2:113-119.
47. Cheng K., Weng W., Wang H., Zhang S. Invitro behavior of osteoblast-like cells on fluoridated hydroxyapatite coatings. Biomaterials 2005, 26:6288-6295.
48. Wang Y., Zhang S., Zeng X., Ma L.L., Weng W., Yan W., et al. Osteoblastic cell response on fluoridated hydroxyapatite coatings. Acta Biomater 2007, 3:191-197.
49. Li J., Song Y., Zhang S., Zhao C., Zhang F., Zhang X., et al. Invitro responses of human bone marrow stromal cells to a fluoridated hydroxyapatite coated biodegradable Mg-Zn alloy. Biomaterials 2010, 31:5782-5788.
50. Kim H.-W., Kim H.-E., Knowles J.C. Fluor-hydroxyapatite sol-gel coating on titanium substrate for hard tissue implants. Biomaterials 2004, 25:3351-3358.
51. Ma L., Qin H., Cheng C., Xia Y., He C., Nie C., et al. Mussel-inspired self-coating at macro-interface with improved biocompatibility and bioactivity via dopamine grafted heparin-like polymers and heparin. JMater Chem B 2014, 2:363-375.
52. Carter W.G., Wayner E.A., Bouchard T.S., Kaur P. The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells. JCell Biol 1990, 110:1387-1404.
53. Santini M.T., Rainaldi G., Ferrante A., Indovina P., Donelli G., Indovina P.L. A50 Hz sinusoidal magnetic field does not damage MG-63 three-dimensional tumor spheroids but induces changes in their invasive properties. Bioelectromagnetics 2006, 27:132-141.
54. Nebe J.B., Müller L., Lüthen F., Ewald A., Bergemann C., Conforto E., et al. Osteoblast response to biomimetically altered titanium surfaces. Acta Biomater 2008, 4:1985-1995.
55. Deligianni D.D., Katsala N.D., Koutsoukos P.G., Missirlis Y.F. Effect of surface roughness of hydroxyapatite on human bone marrow cell adhesion, proliferation, differentiation and detachment strength. Biomaterials 2000, 22:87-96.
56. Kunzler T.P., Drobek T., Schuler M., Spencer N.D. Systematic study of osteoblast and fibroblast response to roughness by means of surface-morphology gradients. Biomaterials 2007, 28:2175-2182.
57. Guldberg R.E., Duvall C.L., Peister A., Oest M.E., Lin A.S., Palmer A.W., et al. 3D imaging of tissue integration with porous biomaterials. Biomaterials 2008, 29:3757-3761.
58. Cazander G., van de Veerdonk M.C., Vandenbroucke-Grauls C.M., Schreurs M.W., Jukema G.N. Maggot excretions inhibit biofilm formation on biomaterials. Clin Orthop Relat R 2010, 468:2789-2796.
59. Wang R., Neoh K.G., Shi Z., Kang E.T., Tambyah P.A., Chiong E. Inhibition of Escherichia coli and Proteus mirabilis adhesion and biofilm formation on medical grade silicone surface. Biotechnol Bioeng 2012, 109:336-345.
60. Hamilton I. Biochemical effects of fluoride on oral bacteria. JDent Res 1990, 69.
61. Busscher H.J., Van der Mei H.C., Subbiahdoss G., Jutte P.C., van den Dungen J.J., Zaat S.A., et al. Biomaterial-associated infection: locating the finish line in the race for the surface. Sci Transl Med 2012, 4:153rv110.
62. Gaharwar A.K., Mihaila S.M., Swami A., Patel A., Sant S., Reis R.L., et al. Bioactive silicate nanoplatelets for osteogenic differentiation of human mesenchymal stem cells. Adv Mater 2013, 25:3329-3336.
63. Montanaro L., Arciola C., Campoccia D., Cervellati M. Invitro effects on MG63 osteoblast-like cells following contact with two roughness-differing fluorohydroxyapatite-coated titanium alloys. Biomaterials 2002, 23:3651-3659.
64. Le Guéhennec L., Soueidan A., Layrolle P., Amouriq Y. Surface treatments of titanium dental implants for rapid osseointegration. Dent Mater 2007, 23:844-854.
65. Lee J.H., Jang H.L., Lee K.M., Baek H.-R., Jin K., Hong K.S., et al. Invitro and invivoevaluation of the bioactivity of hydroxyapatite-coated polyetheretherketone biocomposites created by cold spray technology. Acta Biomater 2013, 9:6177-6187.
66. Taxt-Lamolle S.F., Rubert M., Haugen H.J., Lyngstadaas S.P., Ellingsen J.E., Monjo M. Controlled electro-implementation of fluoride in titanium implant surfaces enhances cortical bone formation and mineralization. Acta Biomater 2010, 6:1025-1032.